[(13)N]ammonia and L-[amide-(13)N]glutamine metabolism in glutaminase-sensitive and glutaminase-resistant murine tumors Journal Article


Authors: Rosenspire, K. C.; Gelbard, A. S.; Cooper, A. J. L.; Schmid, F. A.; Roberts, J.
Article Title: [(13)N]ammonia and L-[amide-(13)N]glutamine metabolism in glutaminase-sensitive and glutaminase-resistant murine tumors
Abstract: The short-term metabolic fate of labeled nitrogen derived from [13N]ammonia or from l-[amide-13N]glutamine was determined in murine tumors known to be resistant (Ridgeway Osteogenic Sarcoma (ROS)) or sensitive (Sarcoma-180 (S-180)) to glutaminase therapy. At 5 min after intraperitoneal injection of [13N]ammonia or of l-[amide-13N]glutamine, only about 0.7% of the label recovered in both tumors was in protein and nucleic acid. After [13N]ammonia administration, most of the label (over 80%) was in a metabolized form; a large portion of this metabolized label (50-57%) was in the urea fraction with a smaller amount in glutamine (37-42%). The major short-term fate of label derived from l-[amide-13N]glutamine was incorporation into components of the urea cycle with smaller amounts in the acidic metabolites and in acidic amino acids. No labeled urea was found during in vitro studies in which S-180 tumor slices were incubated with [13N]ammonia, suggesting that the [13N]urea formed in the tumor in the in vivo experiments was not due to de novo synthesis through carbamyl phosphate in the tumor. Both tumors exhibited very low glutamine synthetase activity. Following glutaminase treatment, glutamine synthetase and γ-glutamyltransferase activities, while remaining low, increased in the resistant tumor but not in the sensitive tumor; this increase may be related to the insensitivity of the ROS tumor toward glutaminase treatment. © 1985.
Keywords: nonhuman; animal cell; mouse; animal; metabolism; mice; in vitro study; drug resistance; sarcoma; blood; liver; biosynthesis; amino acid; radioisotope; amino acids; tumor; gamma glutamyltransferase; blood volume; glutamine; in vitro; urea; ammonia; sarcoma, experimental; gamma-glutamyltransferase; glutamate ammonia ligase; glutamate-ammonia ligase; female; priority journal; article; support, non-u.s. gov't; support, u.s. gov't, p.h.s.; support, u.s. gov't, non-p.h.s.; sarcoma 180; (murine tumor); glutaminase sensitivity; glutaminase
Journal Title: Biochimica et Biophysica Acta (BBA) - General Subjects
Volume: 843
Issue: 1-2
ISSN: 0304-4165
Publisher: Elsevier B.V.  
Date Published: 1985-11-22
Start Page: 37
End Page: 48
Language: English
DOI: 10.1016/0304-4165(85)90047-9
PUBMED: 2865980
PROVIDER: scopus
DOI/URL:
Notes: Article -- Export Date: 26 October 2021 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Franz A. Schmid
    26 Schmid
  2. Alan S. Gelbard
    21 Gelbard
Related MSK Work